Interestingly, recent studies suggest that blood-borne tumor-derived leukemia inhibitory factor (LIF) and galectin-3 (Gal3) may excite the paraventricular nucleus of the hypothalamus, leading to increased sympathetic signaling (181). The gene discussed is LIF; the disease is neoplasm.